Global and Japan Influenza NA Inhibitor Market Insights, Forecast to 2027

Global and Japan Influenza NA Inhibitor Market Insights, Forecast to 2027

  • QYResearch
  • January 2022
  • Pharmaceutical
  • 135 pages

Report Description

Influenza NA Inhibitor market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Influenza NA Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Influenza NA Inhibitor market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Zanamivir
Oseltamivir
Peramivir

Segment by Application
Influenza A Treatment
Influenza B Treatment

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Green Cross
Roche
GlaxoSmithKline
Henan DaKen Chemical
ATK Chemical
Chemwill Asia Co.,Ltd.
Shionogi Co.
NeoPharm
Moksha8 Pharma

Have query on this report?

Make an Enquiry
1 Study Coverage
1.1 Influenza NA Inhibitor Product Introduction
1.2 Market by Type
1.2.1 Global Influenza NA Inhibitor Market Size Growth Rate by Type
1.2.2 Zanamivir
List of Tables
Table 1. Global Influenza NA Inhibitor Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Zanamivir
Table 3. Major Manufacturers of Oseltamivir
Table 4. Major Manufacturers of Peramivir
Table 5. Global Influenza NA Inhibitor Market Size Growth Rate by Application (2021-2027) & (Kilotons)

Success Stories

Our Clients